These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 35911511)

  • 1. Epi-Drugs in Heart Failure.
    Gorica E; Mohammed SA; Ambrosini S; Calderone V; Costantino S; Paneni F
    Front Cardiovasc Med; 2022; 9():923014. PubMed ID: 35911511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leveraging clinical epigenetics in heart failure with preserved ejection fraction: a call for individualized therapies.
    Hamdani N; Costantino S; Mügge A; Lebeche D; Tschöpe C; Thum T; Paneni F
    Eur Heart J; 2021 May; 42(20):1940-1958. PubMed ID: 36282124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leveraging clinical epigenetics in heart failure with preserved ejection fraction: a call for individualized therapies.
    Hamdani N; Costantino S; Mügge A; Lebeche D; Tschöpe C; Thum T; Paneni F
    Eur Heart J; 2021 May; 42(20):1940-1958. PubMed ID: 33948637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic remodeling in heart failure with preserved ejection fraction.
    Ambrosini S; Gorica E; Mohammed SA; Costantino S; Ruschitzka F; Paneni F
    Curr Opin Cardiol; 2022 May; 37(3):219-226. PubMed ID: 35275888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-coding RNAs in the pathophysiology of heart failure with preserved ejection fraction.
    Jalink EA; Schonk AW; Boon RA; Juni RP
    Front Cardiovasc Med; 2023; 10():1300375. PubMed ID: 38259314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of epigenetic drugs in sensitizing cancers to anticancer therapies: emerging trends and clinical advancements.
    Singh D; Khan MA; Siddique HR
    Epigenomics; 2023 Apr; 15(8):517-537. PubMed ID: 37313832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetics Mechanism and Therapeutic Potential of Approved Epi-drugs in Pulmonary Hypertension Disease.
    Zhanqiang L; Huoqiang H; Dianxiang L
    Curr Top Med Chem; 2023; 23(18):1715-1726. PubMed ID: 37013430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenomics in stress tolerance of plants under the climate change.
    Kumar M; Rani K
    Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disentangling the epigenetic landscape in cardiovascular patients: a path toward personalized medicine.
    Ambrosini S; Mohammed SA; Costantino S; Paneni F
    Minerva Cardiol Angiol; 2021 Jun; 69(3):331-345. PubMed ID: 32996305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation of bone remodeling and bone metastasis.
    Sharma G; Sultana A; Abdullah KM; Pothuraju R; Nasser MW; Batra SK; Siddiqui JA
    Semin Cell Dev Biol; 2024 Feb; 154(Pt C):275-285. PubMed ID: 36379849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction.
    Alex L; Russo I; Holoborodko V; Frangogiannis NG
    Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H934-H949. PubMed ID: 30004258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs That Ameliorate Epicardial Adipose Tissue Inflammation May Have Discordant Effects in Heart Failure With a Preserved Ejection Fraction as Compared With a Reduced Ejection Fraction.
    Packer M
    J Card Fail; 2019 Dec; 25(12):986-1003. PubMed ID: 31541742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetics in heart failure phenotypes.
    Berezin A
    BBA Clin; 2016 Dec; 6():31-7. PubMed ID: 27335803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the Delivery and Development of Epigenetic Therapeutics for the Treatment of Cancer.
    Ghosh A; Himaja A; Biswas S; Kulkarni O; Ghosh B
    Mol Pharm; 2023 Dec; 20(12):5981-6009. PubMed ID: 37899551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epigenetic landscape in the cardiovascular complications of diabetes.
    Costantino S; Ambrosini S; Paneni F
    J Endocrinol Invest; 2019 May; 42(5):505-511. PubMed ID: 30291588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics.
    Duan YT; Sangani CB; Liu W; Soni KV; Yao Y
    Curr Top Med Chem; 2019; 19(12):972-994. PubMed ID: 31161992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a robust mouse model of heart failure with preserved ejection fraction.
    Matsiukevich D; Kovacs A; Li T; Kokkonen-Simon K; Matkovich SJ; Oladipupo SS; Ornitz DM
    Am J Physiol Heart Circ Physiol; 2023 Aug; 325(2):H203-H231. PubMed ID: 37204871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic Remodeling in Obesity-Related Vascular Disease.
    Masi S; Ambrosini S; Mohammed SA; Sciarretta S; Lüscher TF; Paneni F; Costantino S
    Antioxid Redox Signal; 2021 May; 34(15):1165-1199. PubMed ID: 32808539
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.